Rasime KALKAN, Karar SHUKUR, Mustafa GAZİ, Hayrettin Ozan GÜLCAN, Amirhossein FALLAH, Kerem TERALI

3-Hydroxy-7,8,9,10-tetrahydro-6H-benzo[c]chromen-6-one and 3-hydroxy-6H-benzo[c] chromen-6-one act as on-off selective fluorescent sensors for Iron (III) under in vitro and ex vivo conditions

Regarding the abundant use of metals for different purposes, it becomes more critical from various scientific and technological perspectives to discover novel agents as selective probes for the detection of specific metals. In our previous studies, we have shown that aqueous solutions of natural urolithins (i.e., hydroxyl-substituted benzo[c]chromen-6-one derivatives) are selective Iron (III) sensors in fluorescence assays. In this study, we have extrapolated these findings to another coumarine compound (i.e., 3-Hydroxy-7,8,9,10- tetrahydro-6H-benzo[c]chromen-6-one) and compared the selective metal binding properties with Urolithin B (i.e., 3-Hydroxy-6Hbenzo[c]chromen-6-one). Following the synthesis and structure identification studies, the fluorometric studies pointed out that the lactam group in the structure still persists to be the important scaffold for maintaining selective on-off sensor capacity that renders the compound a selective Iron (III) binding probe. Moreover, for the first time, fluorescence cellular imaging studies concomitant to cytotoxicity assays with the title compounds were also performed and the results displayed the cell-penetrative, safe, and fluorescent detectable characteristics of the compounds in neuroblastoma and glioblastoma cells through servings as intracellular Iron (III) on-offsensors.

PDF

___

1. Sivaraman G, Iniya M, Anand T, Kotla N.G, Sunnapu O et al. Chemically diverse small molecule fluorescent chemosensors for copper ion. Coordination Chemistry Reviews 2018; 357: pp.50-104.
2. Fu Y, and Finney N.S. Small-molecule fluorescent probes and their design. RSC Advances 2018; 8 (51): 29051-29061.
3. Ugarte M, Osborne N.N, Brown L.A, Bishop P.N. Iron, zinc, and copper in retinal physiology and disease. Survey of Ophthalmology 2013; 58 (6): 585-609.
4. Andreini C, Bertini I, Cavallaro G, Holliday G.L, Thornton J.M. Metal ions in biological catalysis from enzyme databases to general principles. JBIC Journal of Biological Inorganic Chemistry 2008; 13 (8): 1205-1218.
5. Jaishankar M, Tseten T, Anbalagan N, Mathew B.B, and Beeregowda K.N. Toxicity, mechanism and health effects of some heavy metals: Interdisciplinary toxicology 2014; 7(2): pp.60-72.
6. Jomova K, and Valko M. Advances in metal-induced oxidative stress and human disease: Toxicology 2011; 283(2-3): pp.65-87.
7. Miret S, Simpson R.J, and McKie A.T. Physiology and molecular biology of dietary iron absorption: Annual review of nutrition 2003; 23(1): pp.283-301.
8. Rouault T.A. Linking physiological functions of iron: Nature chemical biology 2005; 1(4): pp.193-194.
9. Smith M.A, Harris P.L, Sayre L.M, and Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals: Proceedings of the National Academy of Sciences 1997; 94(18): pp.9866-9868.
10. Oakley A.E, Collingwood J.F, Dobson J, Love G, Perrott H.R, Edwardson J.A, Elstner M, and Morris C.M. Individual dopaminergic neurons show raised iron levels in Parkinson disease: Neurology 2007; 68(21): pp.1820-1825.
11. Fallah A, Gülcan H.O, and Gazi M. Urolithin B as a simple, selective, fluorescent probe for sensing Iron (III) in semi-aqueous solution: Journal of fluorescence 2018; 28(5): pp.1255-1259.
12. Fallah A, Noshadi B, Gazi M, and Gülcan H.O. Urolithin A and B Derivatives as ON-OFF Selective Fluorescent Sensors for Iron (III): Journal of Fluorescence 2020; 30(1): pp.113-120.
13. Norouzbahari M, Burgaz E.V, Ercetin T, Fallah A, Foroumadi A, Firoozpour L, Sahin M.F, Gazi M, and Gulcan H.O. Design, synthesis and characterization of novel urolithin derivatives as cholinesterase inhibitor agents: Letters in Drug Design & Discovery 2018; 15(11): pp.1131-1140.
14. Noshadi B, Ercetin T, Luise C, Yuksel M.Y, Sippl W, Sahin M.F, Gazi M, and Gulcan H.O. Synthesis, Characterization, Molecular Docking, and Biological Activities of Some Natural and Synthetic Urolithin Analogs: Chemistry & Biodiversity 2020;17(8): p.e2000197.
15. Gulcan H.O, Unlu S, Esiringu İ, Ercetin T, Sahin Y, Oz D, and Sahin M.F. Design, synthesis and biological evaluation of novel 6H-benzo [c] chromen-6-one, and 7, 8, 9, 10-tetrahydro-benzo [c] chromen-6-one derivatives as potential cholinesterase inhibitors: Bioorganic & medicinal chemistry 2014; 22(19): pp.5141-5154.
16. Zhang J, Shi D, Zhang H, Xu Z, Bao H, Jin H, and Liu Y. Synthesis of dibenzopyranones and pyrazolobenzopyranones through copper (0)/ Selectfluor system-catalyzed double CH activation/oxygen insertion of 2-arylbenzaldehydes and 5-arylpyrazole-4-carbaldehydes: Tetrahedron 2017; 73(2): pp.154-163.
17. Sarih N.M, Alexander C, Stephen M, Peter M, Anna G.S, Zanariah A, Hairul A.T, Simon M. Furo [3, 2-c] coumarin-derived Fe 3+ Selective Fluorescence Sensor: Synthesis, Fluorescence Study and Application to Water Analysis: Scientific reports 2020; 10(1): pp. 1-11.
18. Cao X., Zhang F, Bai, Y, Ding X, Sun W. A highly selective “Turn-on” fluorescent probe for detection of Fe 3+ in cells: Journal of fluorescence, 2019; 29(2): pp. 425-434.
19. Sahoo S.K, Crisponi G. Recent advances on iron (III) selective fluorescent probes with possible applications in bioimaging: Molecules 2019; 24(18): pp. 3267.
20. Zhou B, Wang J, Zheng G, Qiu Z. Methylated urolithin A, the modified ellagitannin-derived metabolite, suppresses cell viability of DU145 human prostate cancer cells via targeting miR-21: Food and chemical toxicology 2016; 97: pp. 375-384.